Skip to Content

Detectnet FDA Approval History

Last updated by Judith Stewart, BPharm on Oct 27, 2020.

FDA Approved: Yes (First approved September 3, 2020)
Brand name: Detectnet
Generic name: copper Cu 64 dotatate
Dosage form: Injection
Company: RadioMedix Inc.
Treatment for: Positron Emission Tomography Imaging

Detectnet (copper Cu 64 dotatate) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.

Development Timeline for Detectnet

DateArticle
Sep  8, 2020Approval  FDA Approves Detectnet (copper Cu 64 dotatate injection) Positron Emission Tomography (PET) Agent

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.